Tocilizumab (humanized anti IL-6 receptor monoclonal antibody) in patients with systemic lupus erythematosus (SLE): Safety, tolerability and preliminary efficacy.

被引：0
|
作者：
Illei, Gabor G.
Yarboro, Cheryl
Shirota, Yuko
Tackey, Edward
Lapteva, Larissa
Fleisher, Thomas
Balow, James
Lipsky, Peter
机构：
[1] NIH, NIDCR, Bethesda, MD USA
[2] NIAMS, Bethesda, MD USA
[3] NIDCR, Bethesda, MD USA
[4] CC, Bethesda, MD USA
[5] NIDDK, Bethesda, MD USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4043 / 4043
页数：1
相关论文
共 50 条
  • [1] Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus
    Hasni, Sarfaraz
    Gupta, Sarthak
    Davis, Michael
    Poncio, Elaine
    Temesgen-Oyelakin, Yenealem
    Joyal, Elizabeth
    Fike, Alice
    Manna, Zerai
    Auh, Sungyoung
    Shi, Yinghui
    Chan, Diana
    Carlucci, Philip
    Biehl, Ann
    Dema, Barbara
    Charles, Nicolas
    Balow, James E.
    Waldman, Meryl
    Siegel, Richard M.
    Kaplan, Mariana J.
    Rivera, Juan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71 (07) : 1135 - 1140
  • [2] Tocilizumab - A humanized anti-IL-6 receptor monoclonal antibody for the treatment of rheumatoid arthritis
    Schlesselman, Lauren S.
    Hussey, Aaron P.
    [J]. FORMULARY, 2008, 43 (08) : 272 - 279
  • [3] DNA microarray analysis of SLE related genes that respond to IL-6 blockade with tocilizumab, an anti-IL-6 receptor monoclonal antibody
    Ishikawa, S.
    Aoki, C.
    Yoshio, N.
    Nakahara, H.
    Saito, K.
    Tanaka, Y.
    Kishimoto, T.
    Nishimoto, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 474 - 474
  • [4] IL-6 GENE POLYMORPHISMS IN SLE (SYSTEMIC LUPUS-ERYTHEMATOSUS)
    LINKERISRAELI, M
    PREHN, J
    LI, L
    WALLACE, D
    KLINENBERG, JR
    [J]. JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A50 - A50
  • [5] Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica
    Araki, Manabu
    Matsuoka, Takako
    Aranami, Toshimasa
    Nakamura, Masakazu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Yamamura, Takashi
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 911 - 912
  • [6] Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression
    M Linker-Israeli
    DJ Wallace
    J Prehn
    D Michael
    M Honda
    KD Taylor
    M Paul-Labrador
    N Fischel-Ghodsian
    PA Fraser
    JR Klinenberg
    [J]. Genes & Immunity, 1999, 1 : 45 - 52
  • [7] Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression
    Linker-Israeli, M
    Wallace, DJ
    Prehn, J
    Michael, D
    Honda, M
    Taylor, KD
    Paul-Labrador, M
    Fischel-Ghodsian, N
    Fraser, PA
    Klinenberg, JR
    [J]. GENES AND IMMUNITY, 1999, 1 (01) : 45 - 52
  • [8] Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases
    Alten, Rieke
    Maleitzke, Tazio
    [J]. ANNALS OF MEDICINE, 2013, 45 (04) : 357 - 363
  • [9] Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 122
  • [10] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115
12345